4.6 Review

An Emerging Role for the Unfolded Protein Response in Pancreatic Cancer

Journal

CANCERS
Volume 13, Issue 2, Pages -

Publisher

MDPI
DOI: 10.3390/cancers13020261

Keywords

activating transcription factor 6 (ATF6); endoplasmic reticulum (ER); inositol-requiring enzyme 1 (IRE1); protein kinase RNA-like ER kinase (PERK); unfolded protein response (UPR)

Categories

Funding

  1. Precision Oncology Ireland - Science Foundation Ireland Strategic Partnership Programme [18/SPP/3522]
  2. Science Foundation Ireland (SFI) grant under the European Regional Development Fund [13/RC/2073]
  3. EU H2020 MSCA [RISE-734749]
  4. Canada Research Chairs program
  5. SFI Industry Fellowship [18/IF/6247]

Ask authors/readers for more resources

Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer with poor treatment outcomes. A major challenge in PDAC treatment strategies is the dense stroma surrounding tumor cells, shielding them from treatment. The unfolded protein response (UPR) may play a role in the progression and therapy resistance of PDAC.
Simple Summary Pancreatic cancer refers to a group of malignancies of which pancreatic ductal adenocarcinoma (PDAC) is the most common form. It is an aggressive tumour with few treatment options and very poor outcomes. There is an unmet need for novel targeted therapies for PDAC. In this regard, a better understanding of PDAC biology and in particular new pathways that contribute to disease progression would help identify novel targets for therapeutic intervention. Growing evidence implicates the unfolded protein response (UPR) in many cancers, and this article explores the evidence that supports a role for the UPR in PDAC. Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer and one of the leading causes of cancer-associated deaths in the world. It is characterised by dismal response rates to conventional therapies. A major challenge in treatment strategies for PDAC is the presence of a dense stroma that surrounds the tumour cells, shielding them from treatment. This unique tumour microenvironment is fuelled by paracrine signalling between pancreatic cancer cells and supporting stromal cell types including the pancreatic stellate cells (PSC). While our molecular understanding of PDAC is improving, there remains a vital need to develop effective, targeted treatments. The unfolded protein response (UPR) is an elaborate signalling network that governs the cellular response to perturbed protein homeostasis in the endoplasmic reticulum (ER) lumen. There is growing evidence that the UPR is constitutively active in PDAC and may contribute to the disease progression and the acquisition of resistance to therapy. Given the importance of the tumour microenvironment and cytokine signalling in PDAC, and an emerging role for the UPR in shaping the tumour microenvironment and in the regulation of cytokines in other cancer types, this review explores the importance of the UPR in PDAC biology and its potential as a therapeutic target in this disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available